Annual CFI
-$3.22 M
-$2.53 M-368.12%
31 December 2023
Summary:
ADC Therapeutics SA annual cash flow from investing activities is currently -$3.22 million, with the most recent change of -$2.53 million (-368.12%) on 31 December 2023. During the last 3 years, it has fallen by -$388.00 thousand (-13.72%). ADCT annual CFI is now -368.12% below its all-time high of -$687.00 thousand, reached on 31 December 2022.ADCT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$216.00 K
-$186.00 K-620.00%
30 September 2024
Summary:
ADC Therapeutics SA quarterly cash flow from investing activities is currently -$216.00 thousand, with the most recent change of -$186.00 thousand (-620.00%) on 30 September 2024. Over the past year, it has increased by +$445.00 thousand (+67.32%). ADCT quarterly CFI is now -112.68% below its all-time high of $1.70 million, reached on 31 December 2022.ADCT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$1.10 M
+$445.00 K+28.73%
30 September 2024
Summary:
ADC Therapeutics SA TTM cash flow from investing activities is currently -$1.10 million, with the most recent change of +$445.00 thousand (+28.73%) on 30 September 2024. Over the past year, it has increased by +$81.00 thousand (+6.84%). ADCT TTM CFI is now -332.94% below its all-time high of -$255.00 thousand, reached on 31 March 2023.ADCT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADCT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -368.1% | +67.3% | +6.8% |
| 3 y3 years | -13.7% | +90.8% | +83.4% |
| 5 y5 years | -28.3% | - | - |
ADCT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -368.1% | +51.8% | -112.7% | +90.8% | -332.9% | +85.2% |
| 5 y | 5 years | -368.1% | +51.8% | -112.7% | +92.4% | -332.9% | +85.2% |
| alltime | all time | -368.1% | +51.8% | -112.7% | +92.4% | -332.9% | +85.2% |
ADC Therapeutics SA Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$216.00 K(+620.0%) | -$1.10 M(-28.7%) |
| June 2024 | - | -$30.00 K(-94.4%) | -$1.55 M(-43.3%) |
| Mar 2024 | - | -$531.00 K(+62.4%) | -$2.73 M(-15.1%) |
| Dec 2023 | -$3.22 M(+368.1%) | -$327.00 K(-50.5%) | -$3.22 M(+171.4%) |
| Sept 2023 | - | -$661.00 K(-45.5%) | -$1.19 M(+52.3%) |
| June 2023 | - | -$1.21 M(+19.3%) | -$778.00 K(+205.1%) |
| Mar 2023 | - | -$1.02 M(-159.6%) | -$255.00 K(-62.9%) |
| Dec 2022 | -$687.00 K(-89.7%) | $1.70 M(-770.9%) | -$687.00 K(-78.7%) |
| Sept 2022 | - | -$254.00 K(-63.1%) | -$3.22 M(-39.3%) |
| June 2022 | - | -$689.00 K(-52.4%) | -$5.30 M(-28.9%) |
| Mar 2022 | - | -$1.45 M(+74.5%) | -$7.46 M(+11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$6.67 M(+136.0%) | -$830.00 K(-64.5%) | -$6.67 M(+0.6%) |
| Sept 2021 | - | -$2.34 M(-17.9%) | -$6.64 M(+16.4%) |
| June 2021 | - | -$2.85 M(+333.5%) | -$5.70 M(+90.7%) |
| Mar 2021 | - | -$657.00 K(-17.2%) | -$2.99 M(+5.7%) |
| Dec 2020 | -$2.83 M(+25.8%) | -$793.00 K(-43.4%) | -$2.83 M(+39.0%) |
| Sept 2020 | - | -$1.40 M(+915.2%) | -$2.04 M(+221.0%) |
| June 2020 | - | -$138.00 K(-72.2%) | -$634.00 K(+27.8%) |
| Mar 2020 | - | -$496.00 K | -$496.00 K |
| Dec 2019 | -$2.25 M(-10.3%) | - | - |
| Dec 2018 | -$2.51 M(-22.8%) | - | - |
| Dec 2017 | -$3.25 M | - | - |
FAQ
- What is ADC Therapeutics SA annual cash flow from investing activities?
- What is the all time high annual CFI for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual CFI year-on-year change?
- What is ADC Therapeutics SA quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly CFI year-on-year change?
- What is ADC Therapeutics SA TTM cash flow from investing activities?
- What is the all time high TTM CFI for ADC Therapeutics SA?
- What is ADC Therapeutics SA TTM CFI year-on-year change?
What is ADC Therapeutics SA annual cash flow from investing activities?
The current annual CFI of ADCT is -$3.22 M
What is the all time high annual CFI for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual cash flow from investing activities is -$687.00 K
What is ADC Therapeutics SA annual CFI year-on-year change?
Over the past year, ADCT annual cash flow from investing activities has changed by -$2.53 M (-368.12%)
What is ADC Therapeutics SA quarterly cash flow from investing activities?
The current quarterly CFI of ADCT is -$216.00 K
What is the all time high quarterly CFI for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly cash flow from investing activities is $1.70 M
What is ADC Therapeutics SA quarterly CFI year-on-year change?
Over the past year, ADCT quarterly cash flow from investing activities has changed by +$445.00 K (+67.32%)
What is ADC Therapeutics SA TTM cash flow from investing activities?
The current TTM CFI of ADCT is -$1.10 M
What is the all time high TTM CFI for ADC Therapeutics SA?
ADC Therapeutics SA all-time high TTM cash flow from investing activities is -$255.00 K
What is ADC Therapeutics SA TTM CFI year-on-year change?
Over the past year, ADCT TTM cash flow from investing activities has changed by +$81.00 K (+6.84%)